The virus never really left, and now it’s switching up again. The BA.3.2 COVID-19 variant, nicknamed “Cicada,” is picking up speed in multiple regions, and health officials are paying attention as case numbers trend upward.
BA.3.2, a newer subvariant of COVID-19, has been identified through ongoing genomic surveillance, with early data suggesting it spreads efficiently, similar to past Omicron-line strains. While it hasn’t been officially labeled more severe, the pace of transmission is what’s raising eyebrows.
The “Cicada” nickname didn’t come from scientists but from online chatter, likely referencing how suddenly and loudly it seems to be showing up. Still, behind the name is a familiar pattern. A highly transmissible strain, subtle symptom shifts, and a public that’s a little less on guard than before.
Health agencies including the Centers for Disease Control and Prevention continue monitoring variants like BA.3.2 as part of standard surveillance. So far, there is no indication that this variant causes more severe illness than previous strains, but like earlier versions, it can still pose risks for older adults and those with underlying conditions.
What’s catching attention, though, is how symptoms are presenting. While some overlap with earlier Omicron variants, reports suggest a mix of upper respiratory issues and fatigue that people initially brush off as allergies or a mild cold.
Reported Symptoms of BA.3.2 “Cicada” Variant:
- Persistent dry or mild cough
- Fatigue or unusual tiredness
- Sore throat
- Runny or congested nose
- Headache
- Low-grade fever or chills
- Muscle aches
- Occasional loss of taste or smell, though less common than earlier strains
- Shortness of breath in more serious cases
Because symptoms can appear mild at first, some cases may go undetected, which contributes to the faster spread. Testing and awareness still play a role, especially for those in close-contact environments.
Vaccines and updated boosters remain the primary defense, according to public health guidance, helping reduce the risk of severe illness, hospitalization, and complications.
